NCT07679984Not yet recruiting
Evaluating the Effects of a Mindfulness Intervention on Health Outcomes in Individuals With Hypertension
Source: ClinicalTrials.gov · Last updated 6 Jul 2026
Brief summary (registry, in English)
The purpose of this study is to evaluate the effectiveness of adding the Mindfulness in Motion (MIM) program to usual primary care for people with high blood pressure. MIM is a facilitated, 8-week online program that teaches simple ways to manage stress using mindfulness practices. The program also includes the use of a companion smartphone app throughout the 12-month study period. In this study, investigators will compare people who receive their usual care and take part in the MIM program with those who receive usual care alone to see if it helps improve blood pressure, weight, stress, sleep, and overall well-being. Over 12 months, participants will be asked to complete short questionnaires about stress, sleep, and resilience four times via a smartphone, tablet, or computer.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- First submitted
- 22 Jun 2026
- Start date
- 1 Oct 2026
- Primary completion date
- 1 Oct 2027
- Lead sponsor
- Ohio State University
- Diseases
- High blood pressure
- NCT number
- NCT07679984
What you commit to
- Study type: Interventional
- Planned participants: 140
- From 1 Oct 2026 to the primary completion date, 1 Oct 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis of secondary hypertension with identifiable underlying causes including:
- Chronic kidney disease
- Renal artery stenosis
- Primary aldosteronism
- Cushing's syndrome
- Pheochromocytoma
- Obstructive sleep apnea
- Medication induced hypertension (e.g., steroids, NSAIDs)
- Pregnancy related hypertension
- Current severe alcohol or substance abuse disorder.
- Participants with documented cognitive disorder that limits the ability to independently participate in MIM program, read, understand, and/or complete the surveys; i.e. dementia, Alzheimer's or biological tests.
- Participants with major psychiatric disorders not controlled by medication or other psychiatric treatments.
Other
- Inability to read and/or understand English (MIM intervention, study consent and questionnaires in English).
- Established mindfulness practice.
Who the study is looking for
- Age \>18 years old.
- Established patient at OSU Family Medicine
- Diagnosis of primary essential hypertension
- Ability and willingness to participate in all Mindfulness in Motion (MIM) study activities.
- Ability and willingness to download MyCap, the smartphone app that securely links participant study responses to the REDCap study project.
- WiFi connectivity or LTE to allow use of MIM smartphone app and MyCap when not at OSU clinical site.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Ohio State University -Wexner Medical Center Coordinator of this site? Confirm its status | Columbus | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.